Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

"In vitro systems to characterize the immune response to HIV-1 and HIV-1 vaccine candidates", NIAID Workshop Report, Bethesda, August 4, 2010.

Malaspina A, Rinaldo CR, Sekaly RP, Flores J, D'Souza PM.

Vaccine. 2011 Jun 24;29(29-30):4647-53. doi: 10.1016/j.vaccine.2011.04.035. Epub 2011 May 14.

PMID:
21571022
[PubMed - indexed for MEDLINE]
2.

Innate immunity in HIV infection and implications for vaccine design: a summary of the workshop held at the National Institute of Allergy and Infectious Diseases, Bethesda on February 25-26, 2010.

Bansal GP, Leitner WW.

Vaccine. 2010 Dec 6;28(52):8229-35. doi: 10.1016/j.vaccine.2010.10.073. Epub 2010 Nov 10.

PMID:
21073990
[PubMed - indexed for MEDLINE]
3.

HIV vaccine research: the way forward.

Fauci AS, Johnston MI, Dieffenbach CW, Burton DR, Hammer SM, Hoxie JA, Martin M, Overbaugh J, Watkins DI, Mahmoud A, Greene WC.

Science. 2008 Jul 25;321(5888):530-2. doi: 10.1126/science.1161000.

PMID:
18653883
[PubMed - indexed for MEDLINE]
4.

HIV-1 vaccines and adaptive trial designs.

Corey L, Nabel GJ, Dieffenbach C, Gilbert P, Haynes BF, Johnston M, Kublin J, Lane HC, Pantaleo G, Picker LJ, Fauci AS.

Sci Transl Med. 2011 Apr 20;3(79):79ps13. doi: 10.1126/scitranslmed.3001863.

PMID:
21508308
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Genetically identical primate modelling systems for HIV vaccines.

Kent SJ, Lewis IM.

Reprod Fertil Dev. 1998;10(7-8):651-7. Review.

PMID:
10612472
[PubMed - indexed for MEDLINE]
6.

Workshop summary: Novel biomarkers for HIV incidence assay development.

Sharma UK, Schito M, Welte A, Rousseau C, Fitzgibbon J, Keele B, Shapiro S, McMichael A, Burns DN.

AIDS Res Hum Retroviruses. 2012 Jun;28(6):532-9. doi: 10.1089/AID.2011.0332. Epub 2012 Feb 24.

PMID:
22206265
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Enrollment of racial/ethnic minorities in NIAID-funded networks of HIV vaccine trials in the United States, 1988 to 2002.

Djomand G, Katzman J, di Tommaso D, Hudgens MG, Counts GW, Koblin BA, Sullivan PS.

Public Health Rep. 2005 Sep-Oct;120(5):543-8.

PMID:
16224987
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

HIV vaccine development at the turn of the 21st century.

Girard MP, Plotkin SA.

Curr Opin HIV AIDS. 2012 Jan;7(1):4-9. doi: 10.1097/COH.0b013e32834ddc96. Review.

PMID:
22156840
[PubMed - indexed for MEDLINE]
9.

Challenges in the development of an HIV-1 vaccine.

Barouch DH.

Nature. 2008 Oct 2;455(7213):613-9. doi: 10.1038/nature07352. Review.

PMID:
18833271
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Long-term safety analysis of preventive HIV-1 vaccines evaluated in AIDS vaccine evaluation group NIAID-sponsored Phase I and II clinical trials.

Gilbert PB, Chiu YL, Allen M, Lawrence DN, Chapdu C, Israel H, Holman D, Keefer MC, Wolff M, Frey SE; NIAID HIV Vaccine Trials Network.

Vaccine. 2003 Jun 20;21(21-22):2933-47.

PMID:
12798637
[PubMed - indexed for MEDLINE]
11.

Working group consultation: alloimmunity as a vaccine approach against HIV/AIDS: National Institutes of Health Meeting Report, May 24, 2012.

Singh A, Warren J, Schultz A, Hackett CJ, Sharma O.

AIDS Res Hum Retroviruses. 2013 Jun;29(6):851-8. doi: 10.1089/AID.2013.0041. Epub 2013 Apr 23.

PMID:
23530996
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

NIAID HIV/AIDS vaccine research. National Institute of Allergy and Infectious Diseases.

[No authors listed]

NIAID AIDS Agenda. 1997 Aug:4.

PMID:
11364611
[PubMed - indexed for MEDLINE]
13.

Predictive value of primate models for AIDS.

Haigwood NL.

AIDS Rev. 2004 Oct-Dec;6(4):187-98. Review.

PMID:
15700617
[PubMed - indexed for MEDLINE]
14.

Progress toward an HIV vaccine.

Letvin NL.

Annu Rev Med. 2005;56:213-23. Review.

PMID:
15660510
[PubMed - indexed for MEDLINE]
15.

New directions for HIV vaccine development from animal models.

McChesney MB, Miller CJ.

Curr Opin HIV AIDS. 2013 Sep;8(5):376-81. doi: 10.1097/COH.0b013e328363d3a2. Review.

PMID:
23836045
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

No acquisition: a new ambition for HIV vaccine development?

Lakhashe SK, Silvestri G, Ruprecht RM.

Curr Opin Virol. 2011 Oct;1(4):246-53. doi: 10.1016/j.coviro.2011.07.005. Review.

PMID:
22081778
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Can HIV infection be prevented with a vaccine?

Joy AK, Dale CJ, Kent SJ.

Drugs R D. 1999 Jun;1(6):431-40. Review.

PMID:
10566076
[PubMed - indexed for MEDLINE]
18.

Human versus HIV: round 2 defeat in AIDS vaccine development.

Lu S.

Expert Rev Vaccines. 2008 Mar;7(2):151-3. doi: 10.1586/14760584.7.2.151. No abstract available.

PMID:
18324884
[PubMed - indexed for MEDLINE]
19.

NIAID to convene HIV vaccine summit.

[No authors listed]

AIDS Patient Care STDS. 2008 Apr;22(4):350-1. No abstract available.

PMID:
18434951
[PubMed - indexed for MEDLINE]
20.

Selected approaches for increasing HIV DNA vaccine immunogenicity in vivo.

Hutnick NA, Myles DJ, Bian CB, Muthumani K, Weiner DB.

Curr Opin Virol. 2011 Oct;1(4):233-40. doi: 10.1016/j.coviro.2011.08.003. Epub 2011 Sep 7. Review.

PMID:
22440782
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk